S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Tesla hikes price of Model Y after US alters tax credit rule
A gold storm is coming… (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Iraqi currency crash halts after meeting with U.S. official
A gold storm is coming… (Ad)
Europe bans Russian diesel, other oil products over Ukraine
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
A gold storm is coming… (Ad)
Gas prices dip in NJ, around nation as cold weather returns
How will EU ban and West's price cap on Russian diesel work?
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Tesla hikes price of Model Y after US alters tax credit rule
A gold storm is coming… (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Iraqi currency crash halts after meeting with U.S. official
A gold storm is coming… (Ad)
Europe bans Russian diesel, other oil products over Ukraine
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
A gold storm is coming… (Ad)
Gas prices dip in NJ, around nation as cold weather returns
How will EU ban and West's price cap on Russian diesel work?
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Tesla hikes price of Model Y after US alters tax credit rule
A gold storm is coming… (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Iraqi currency crash halts after meeting with U.S. official
A gold storm is coming… (Ad)
Europe bans Russian diesel, other oil products over Ukraine
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
A gold storm is coming… (Ad)
Gas prices dip in NJ, around nation as cold weather returns
How will EU ban and West's price cap on Russian diesel work?
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
Tesla hikes price of Model Y after US alters tax credit rule
A gold storm is coming… (Ad)
Route to Super Bowl dangerous for Mexico's avocado haulers
Iraqi currency crash halts after meeting with U.S. official
A gold storm is coming… (Ad)
Europe bans Russian diesel, other oil products over Ukraine
It wasn’t me: Ex-UK PM Truss blames 'system' for her failure
A gold storm is coming… (Ad)
Gas prices dip in NJ, around nation as cold weather returns
How will EU ban and West's price cap on Russian diesel work?
NASDAQ:ERYP

ERYTECH Pharma - ERYP Stock Forecast, Price & News

$1.20
-0.08 (-6.25%)
(As of 02/3/2023 12:00 AM ET)
Add
Compare
Today's Range
$1.08
$1.30
50-Day Range
$0.33
$1.38
52-Week Range
$0.30
$2.18
Volume
39,969 shs
Average Volume
83,314 shs
Market Capitalization
$37.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ERYTECH Pharma MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.22% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.08mentions of ERYTECH Pharma in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($0.43) to ($0.93) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

0.78 out of 5 stars

Medical Sector

1027th out of 1,028 stocks

Biological Products, Except Diagnostic Industry

168th out of 168 stocks

ERYP stock logo

About ERYTECH Pharma (NASDAQ:ERYP) Stock

ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France.

Receive ERYP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ERYTECH Pharma and its competitors with MarketBeat's FREE daily newsletter.

ERYP Stock News Headlines

Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
ERYP ERYTECH Pharma S.A.
ERYTECH Announces Receipt of Nasdaq Notice
European ADRs Move Lower in Monday Trading
See More Headlines
Receive ERYP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ERYTECH Pharma and its competitors with MarketBeat's FREE daily newsletter.

ERYP Company Calendar

Today
2/05/2023
Next Earnings (Estimated)
4/26/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ERYP
Employees
196
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$4.95 million
Book Value
$0.87 per share

Miscellaneous

Free Float
30,417,000
Market Cap
$37.23 million
Optionable
Not Optionable
Beta
2.64

Key Executives

  • Gil Beyen
    Chief Executive Officer & Director
  • Eric Soyer
    Chief Operating & Financial Officer
  • Stewart Craig
    Chief Technical Officer
  • Iman El-Hariry
    Chief Medical Officer
  • Jérôme Bailly
    Chief Quality Officer & Deputy General Manager













ERYP Stock - Frequently Asked Questions

How have ERYP shares performed in 2023?

ERYTECH Pharma's stock was trading at $0.3301 at the beginning of the year. Since then, ERYP stock has increased by 263.6% and is now trading at $1.2001.
View the best growth stocks for 2023 here
.

When is ERYTECH Pharma's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 26th 2023.
View our ERYP earnings forecast
.

What other stocks do shareholders of ERYTECH Pharma own?
When did ERYTECH Pharma IPO?

(ERYP) raised $125 million in an initial public offering (IPO) on Friday, November 10th 2017. The company issued 5,300,000 shares at $23.00-$24.00 per share. Jefferies, Cowen and Oddo BHF served as the underwriters for the IPO and JMP Securities was co-manager.

What is ERYTECH Pharma's stock symbol?

ERYTECH Pharma trades on the NASDAQ under the ticker symbol "ERYP."

Who are ERYTECH Pharma's major shareholders?

ERYTECH Pharma's stock is owned by a variety of retail and institutional investors. Top institutional investors include Concourse Financial Group Securities Inc. (0.00%).

How do I buy shares of ERYTECH Pharma?

Shares of ERYP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ERYTECH Pharma's stock price today?

One share of ERYP stock can currently be purchased for approximately $1.20.

How much money does ERYTECH Pharma make?

ERYTECH Pharma (NASDAQ:ERYP) has a market capitalization of $37.23 million and generates $4.95 million in revenue each year.

How many employees does ERYTECH Pharma have?

The company employs 196 workers across the globe.

How can I contact ERYTECH Pharma?

ERYTECH Pharma's mailing address is 60 AVENUE ROCKEFELLER BATIMENT ADENINE, LYON I0, 69008. The official website for the company is www.erytech.com. The company can be reached via phone at (347) 874-4438, via email at investors@erytech.com, or via fax at 33-4-78-75-56-29.

This page (NASDAQ:ERYP) was last updated on 2/5/2023 by MarketBeat.com Staff